Anzemet and Lymphoedema - a phase IV clinical study of FDA data

Summary:

Lymphoedema is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are female, 40-49 old, also take Zometa, and have Breast cancer.

The phase IV clinical study analyzes which people have Lymphoedema when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Lymphoedema?

Lymphoedema (localized fluid retention and tissue swelling) is found to be associated with 911 drugs and 743 conditions by eHealthMe. Check the latest studies of Lymphoedema.

On Aug, 06, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 36 people (1.4%) have Lymphoedema.

Among these 36 people:

What is the gender of people who have Lymphoedema when taking Anzemet? *

female: 94.29 %
male: 5.71 %

What is the age of people who have Lymphoedema when taking Anzemet? *

What are other drugs people take besides Anzemet? *

What are other side effects people have besides Lymphoedema? *

Pain: 28 people, 77.78%
Pleural Effusion (water on the lungs): 26 people, 72.22%
Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 66.67%
Bone Disorder: 23 people, 63.89%
Anaemia (lack of blood): 22 people, 61.11%
Loose Tooth: 22 people, 61.11%
Rashes (redness): 22 people, 61.11%
Cyst (a closed sac): 22 people, 61.11%
Sinusitis (inflammation of sinus): 21 people, 58.33%
Metastases To Lung (cancer spreads to lung): 21 people, 58.33%

What are the existing conditions these people have? *

Breast Cancer: 29 people, 80.56%
Metastases To Bone (cancer spreads to bone): 25 people, 69.44%
Parkinson's Disease: 10 people, 27.78%
Osteoporosis (bones weak and more likely to break): 10 people, 27.78%
Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 27.78%
Breast Cancer Metastatic: 9 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Urinary Tract Infection: 1 person, 2.78%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.78%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Lymphoedema?

- Check whether Lymphoedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Anzemet (2,603 reports)

Lymphoedema treatments and more:

Lymphoedema (9,453 reports)

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphoedema:

Lymphoedema (911 drugs)

Browse all the conditions that are associated with Lymphoedema:

Lymphoedema (743 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.